Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 5/20 | 0.44 |
| ▸ | CA12 | O43570 | 2/20 | 0.44 |
| ▸ | CA1 | P00915 | 2/20 | 0.44 |
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
| ▸ | CA3 | P07451 | 2/20 | 0.44 |
| ▸ | CA4 | P22748 | 2/20 | 0.44 |
| ▸ | CA6 | P23280 | 2/20 | 0.44 |
| ▸ | CA5A | P35218 | 2/20 | 0.44 |
| ▸ | CA7 | P43166 | 2/20 | 0.44 |
| ▸ | CA9 | Q16790 | 2/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.44 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.44 |
| ▸ | GSR | P00390 | 1/20 | 0.41 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.39 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.36 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.36 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4809730 | 0.88 | NFKB1 (0.35) | DNM1CA12CA1CA2CA3 | |
| SCHEMBL29203887 | 0.85 | TRPV1 (0.39) | DNM1CA12CA1CA2CA3 | |
| SCHEMBL5930765 | 0.81 | DNM1 (0.42) | DNM1CA12CA1CA2CA3 | |
| SCHEMBL10883467 | 0.79 | GSR (0.31) | DNM1CA12CA1CA2CA3 | |
| SCHEMBL23291093 | 0.77 | GNAI3 (0.41) | DNM1CA12CA1CA2CA3 | |
| SCHEMBL8690794 | 0.77 | CA12 (0.38) | DNM1CA12CA1CA2CA3 | |
| SCHEMBL21173981 | 0.77 | GNAI3 (0.41) | DNM1CA12CA1CA2CA3 | |
| SCHEMBL21295453 | 0.77 | GNAI3 (0.41) | DNM1CA12CA1CA2CA3 | |
| SCHEMBL4456371 | 0.77 | GNAI3 (0.41) | DNM1CA12CA1CA2CA3 | |
| SCHEMBL15162843 | 0.77 | GNAI3 (0.41) | DNM1CA12CA1CA2CA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220168278-A1 | LOW DOSE FLURALANER COMPOSITIONS FOR PROTECTION AGAINST PARASITIC INVERTEBRATE PEST | VIRBAC (FR) | 2022-06-02 | — | — | US | disclosed |
| EP-3927341-A1 | LOW DOSE FLURALANER COMPOSITIONS FOR PROTECTION AGAINST PARASITIC INVERTEBRATE PEST | VIRBAC (FR) | 2021-12-29 | — | — | EP | disclosed |
| US-10899932-B2 | Non-amphoteric, quaternisable and water-soluble polymers for modifying the surface charge of solid particles | BASF SE (DE) | 2021-01-26 | — | — | US | disclosed |
| WO-2020201440-A1 | LOW DOSE FLURALANER COMPOSITIONS FOR PROTECTION AGAINST PARASITIC INVERTEBRATE PEST | VIRBAC (FR) | 2020-10-08 | — | — | WO | disclosed |
| US-10759767-B2 | Compositions comprising a triazole compound | BASF Agro B.V. (NL) | 2020-09-01 | — | — | US | disclosed |
| EP-3646731-A1 | PESTICIDAL MIXTURES COMPRISING A PYRAZOLE COMPOUND | BASF SE (DE) | 2020-05-06 | — | — | EP | disclosed |
| EP-3300602-B1 | PESTICIDAL MIXTURES COMPRISING A PYRAZOLE COMPOUND | BASF SE (DE) | 2020-03-25 | — | — | EP | disclosed |
| EP-3498098-A1 | COMPOSITIONS COMPRISING A TRIAZOLE COMPOUND | BASF Agro B.V. (NL) | 2019-06-19 | — | — | EP | disclosed |
| US-20180334569-A9 | NON-AMPHOTERIC, QUATERNISABLE AND WATER-SOLUBLE POLYMERS FOR MODIFYING THE SURFACE CHARGE OF SOLID PARTICLES | BASF SE (DE) | 2018-11-22 | — | — | US | disclosed |
| US-20180296459-A1 | COMPOSITIONS CONTAINING POLYMERIC, IONIC COMPOUNDS COMPRISING IMIDAZOLIUM GROUPS | BASF SE (DE) | 2018-10-18 | — | — | US | disclosed |
| US-20060276468-A1 | Wood preservative formulations comprising Imazalil | OSMOSE, INC. | 2006-12-07 | — | — | US | disclosed |
| US-20060217447-A1 | Wood preservative formulations comprising dichlorophen | OSMOSE, INC. | 2006-09-28 | — | — | US | disclosed |
| WO-2006094127-A1 | WOOD PRESERVATIVE FORMULATIONS COMPRISING DICHLOROPHEN | OSMOSE, INC. (US) | 2006-09-08 | — | — | WO | disclosed |
| US-20050227956-A1 | Control of mold growth on wood | E. I. DU PONT DE NEMOURS AND COMPANY | 2005-10-13 | — | — | US | disclosed |
| EP-0437744-B1 | Fungicidal combination of active agents | BAYER AG (DE) | 1995-01-18 | — | — | EP | disclosed |
| EP-0438712-B1 | FUNGICIDAL COMBINATION OF ACTIVE AGENTS | BAYER AG (DE) | 1993-09-08 | — | — | EP | disclosed |
| US-5135942-A | Synergistic mixture | BAYER AKTIENGESELLSCHAFT (DE) | 1992-08-04 | — | — | US | disclosed |
| US-5126360-A | Synergistic mixture | BAYER AKTIENGESELLSCHAFT (DE) | 1992-06-30 | — | — | US | disclosed |
| EP-0438712-A1 | Fungicidal combination of active agents | BAYER AG (DE) | 1991-07-31 | — | — | EP | disclosed |
| EP-0437744-A2 | Fungicidal combination of active agents | BAYER AG (DE) | 1991-07-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220168278-A1 | LOW DOSE FLURALANER COMPOSITIONS FOR PROTECTION AGAINST PARASITIC INVERTEBRATE PEST | P2RX7, CAT, PDE8A | DNM1 1100/4885CA12 3817/4885CA1 2996/4885 |
| US-20180296459-A1 | COMPOSITIONS CONTAINING POLYMERIC, IONIC COMPOUNDS COMPRISING IMIDAZOLIUM GROUPS | PUF60, POLR1C, PICALM | DNM1 2379/4885CA12 757/4885CA1 2157/4885 |
| US-20050227956-A1 | Control of mold growth on wood | ERG28, AKR7A2, DPM1 | DNM1 2486/4885CA12 1383/4885CA1 1712/4885 |
| US-10759767-B2 | Compositions comprising a triazole compound | CYP1B1, CYP3A5, CYP4B1 | DNM1 4524/4885CA12 2340/4885CA1 2534/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.